Analyst John Newman of Canaccord Genuity maintained a Buy rating on Seres Therapeutics (MCRB – Research Report), retaining the price ...

Joseph Pantginis, an analyst from H.C. Wainwright, reiterated the Buy rating on Capricor Therapeutics (CAPR – Research Report). The ...

The rise of antibody therapeutics is transforming drug discovery, providing highly specific treatments for complex diseases ...

As part of its partnership with NVIDIA, Genesis will seek to enhance the computational strategies in their computation, ...

SAN DIEGO, November 13, 2024--(BUSINESS WIRE)--Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a ...

MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, ...

Chancellor of the Exchequer Rachel Reeves visits Quell Therapeutics in London where she sees how critical it is that funding ...

Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable diseaseColon ...

The global biological safety testing market size was US$ 4.1 billion in 2021. The global biological safety testing market is forecast to grow to US$ 10.8 billion by 2030 by registering a compound ...

Candel is a clinical stage biopharmaceutical company focused on developing off-the-shelf multimodal biological ...

a small molecule inhibiting the biological activity of ETS-family transcription factor oncoproteins, which is in Phase 1/2 clinical trial. Receive News & Ratings for Oncternal Therapeutics Daily - ...